5NTW image
Entry Detail
PDB ID:
5NTW
Title:
Structural states of RORgt: X-ray elucidation of molecular mechanisms and binding interactions for natural and synthetic compounds
Biological Source:
Source Organism:
PDB Version:
Deposition Date:
2017-04-28
Release Date:
2017-06-21
Method Details:
Experimental Method:
Resolution:
1.64 Å
R-Value Free:
0.22
R-Value Work:
0.19
R-Value Observed:
0.20
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Nuclear receptor ROR-gamma
Mutations:C455S
Chain IDs:A, B, C, D
Chain Length:257
Number of Molecules:4
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Nuclear receptor-interacting protein 1
Chain IDs:E (auth: P), F (auth: Q), G (auth: R), H (auth: S)
Chain Length:20
Number of Molecules:4
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Structural States of ROR gamma t: X-ray Elucidation of Molecular Mechanisms and Binding Interactions for Natural and Synthetic Compounds.
ChemMedChem 12 1014 1021 (2017)
PMID: 28590087 DOI: 10.1002/cmdc.201700278

Abstact

The T-cell-specific retinoic acid receptor (RAR)-related orphan receptor-γ (RORγt) is a key transcription factor for the production of pro-inflammatory Th17 cytokines, which are implicated in the pathogenesis of autoimmune diseases. Over the years, several structurally diverse RORγt inverse agonists have been reported, but combining high potency and good physicochemical properties has remained a challenging task. We recently reported a new series of inverse agonists based on an imidazopyridine core with good physicochemical properties and excellent selectivity. Herein we report eight new X-ray crystal structures for different classes of natural and synthetic compounds, including examples selected from the patent literature. Analysis of their respective binding modes revealed insight into the molecular mechanisms that lead to agonism, antagonism, or inverse agonism. We report new molecular mechanisms for RORγt agonism and propose a separation of the inverse agonists into two classes: those that act via steric clash and those that act via other mechanisms (for the latter, co-crystallization with a co-activator peptide and helix 12 in the agonist position is still possible). For the non-steric clash inverse agonists, we propose a new mechanism ("water trapping") which can be combined with other mechanisms (e.g., close contacts with H479). In addition, we compare the interactions made for selected compounds in the "back pocket" near S404 and in the "sulfate pocket" near R364 and R367. Taken together, these new mechanistic insights should prove useful for the design and optimization of further RORγt modulators.

Legend

Protein

Chemical

Disease

Primary Citation of related structures